Literature DB >> 8381952

Sensitive periods for glucocorticoids' regulation of Na+,K(+)-ATPase mRNA in the developing lung and kidney.

G Celsi1, Z M Wang, G Akusjärvi, A Aperia.   

Abstract

We have previously reported that in the infant rat renal cortex, a saturating dose of glucocorticoid hormones (GC) rapidly increases the abundance of Na+,K(+)-ATPase mRNA. We now show that this effect is dose dependent. In the renal cortex of 10-d-old rats, an increase in renal Na+,K(+)-ATPase mRNA occurs with 2.5 micrograms betamethasone/100 g body weight. In subsequent experiments, performed 6 h after a saturating dose (60 micrograms/100 g body weight), we show that the effect is age dependent. The most marked effects on renal cortical alpha-mRNA were found at 10 d of age (5.3- +/- 0.9-fold). A significant increase was also found in 20-d-old rats (1.6- +/- 0.2-fold), but no effect was found in fetal and 5-d-old rats. Studies were also performed on the lung, where the most marked effect was noted in the perinatal period (2.0- +/- 0.1-fold 2 d before birth and 1.76 +/- 0.2 at 5 d of age), but no effect on alpha-mRNA was found at 10 and 20 d. In one protocol, the effect of betamethasone on renal Na+K(+)-ATPase mRNAs abundance was determined in adult adrenalectomized rats. In these rats, betamethasone induced a significant 1.6- +/- 0.2-fold and 1.8- +/- 0.3-fold increase in renal Na+,K(+)-ATPase mRNA. This effect, however, was significantly smaller than the increase induced in intact 10-d-old rats. GC induction of Na+,K(+)-ATPase mRNA is age and tissue dependent and is dependent on factors other than GC-receptor availability. The GC-sensitive period appears to coincide with the physiologic need for organ maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381952     DOI: 10.1203/00006450-199301000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Antenatal steroids: miracle drug for preemies.

Authors:  V K Rehan
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 2.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Regulation of Na+,K(+)-ATPase gene expression: a model to study terminal differentiation.

Authors:  G Celsi; Z M Wang
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

4.  Textbook on endocrinology.

Authors:  P Lee; J Leonard
Journal:  BMJ       Date:  1994-06-04

5.  Influence of antenatal steroids and sex on maturation of the epidermal barrier in the preterm infant.

Authors:  A Jain; N Rutter; P H Cartlidge
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

6.  Perinatal changes in expression of aquaporin-4 and other water and ion transporters in rat lung.

Authors:  M Yasui; E Serlachius; M Löfgren; R Belusa; S Nielsen; A Aperia
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

7.  Antenatal steroids and fluid balance in very low birthweight infants.

Authors:  G Dimitriou; V Kavvadia; M Marcou; A Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-05       Impact factor: 5.747

Review 8.  Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.

Authors:  Melanie E Peffer; Janie Y Zhang; Leah Umfrey; Anthony C Rudine; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Endocrinol       Date:  2015-03-12

9.  Transcriptional regulation by glucocorticoids of mitochondrial oxidative enzyme genes in the developing rat kidney.

Authors:  F Djouadi; J Bastin; D P Kelly; C Merlet-Benichou
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

10.  Fluid and electrolyte balance during the first week of life and risk of bronchopulmonary dysplasia in the preterm neonate.

Authors:  Gustavo Rocha; Orquídea Ribeiro; Hercília Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.